Skip to content

Insider · CIK 0001774182

Fairooz Kabbinavar

officer

Files at CRDF (Cardiff Oncology, Inc.). First filing -, latest -.

In brief

Fairooz Kabbinavar files SEC Form 4 as officer at CRDF (Cardiff Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Fairooz Kabbinavar has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 11, 2025CRDF
Cardiff Oncology, Inc.
AGrant or award
Stock Optionsderivative
+150,000$0.00$0780,008Mar 13, 2025

Questions about Fairooz Kabbinavar

Answered from the filings on this page, as of the latest one.

Is Fairooz Kabbinavar buying or selling?

Fairooz Kabbinavar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Fairooz Kabbinavar's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Fairooz Kabbinavar has 0.

Where does Fairooz Kabbinavar file Form 4?

Fairooz Kabbinavar has filed Form 4 at CRDF (Cardiff Oncology, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Fairooz Kabbinavar: insider trades and track record | InsiderTell